prioriti review voucher smackbot neglect diseas prioriti review voucher prize award develop treatment neglect diseas prize wa propos duke univers faculti henri grabowski jeffrey moe david ridley health affair paper develop drug develop countri senat sam brownback rk sherrod brown doh sponsor amend food drug administr amend presid georg bush sign bill septemb summari prioriti review voucher wa propos ridley grabowski moe lead articl health affair march prize incent compani invest drug vaccin neglect tropic diseas provis food drug administr amend hr award transfer prioriti review voucher ani compani approv treatment neglect tropic diseas sponsor senat sam brownback rk sherrod brown doh thi provis add market base incent avail develop medicin develop diseas malaria tuberculosi african sleep sick mechan statut author fda award prioriti review voucher sponsor manufactur newli approv drug biolog target neglect tropic diseas provis appli drug applic nda biolog licens applic bla applicationsth voucher transfer sold entitl bearer prioriti review anoth product current prescript drug user fee target fda aim complet review prioriti drug month standard month review period actual fda review timelin howev longer target pdufa review period particularli product haven previous approv economist duke univers publish thi concept estim prioriti review cut fda review process averag month month shorten full year time compani drug reach market compani top sell drug net valu close billion duke calcul acceler approv worth thi level voucher expect offset substanti invest risk requir discoveri develop treatment neglect diseas time save gain prioriti review shorter howev valu voucher will significantli fact median standard review time month voucher cut month standard review period intang benefit voucher valu creat compani faster review provid mover advantag allow voucher holder product introduc ahead compet product advantag exist market forc patient develop faster access lifesav product otherwis develop sponsor neglect diseas drug reward innov compani voucher will requir pay supplement prioriti review user fee ensur fda recoup cost incur agenc faster review addit user fee aim ensur program will slow progress product await fda review diseas target tropic diseas will benefit includ follow tuberculosi malaria blind trachoma buruli ulcer cholera dengu dengu haemorrhag fever dracunculiasi guineaworm diseas fascioliasi human african trypanosomiasi leishmaniasi leprosi lymphat filariasi onchocerciasi schistosomiasi soil transmit helmithiasi yaw ani infecti diseas signific market develop nation disproportion affect poor margin popul amend amend food drug administr amend news reaction highestleverag work govern set polici disburs fund creat market incent busi activ improv live poor law sign presid bush year ani drug compani develop treatment neglect diseas malaria tb prioriti review food drug administr anoth product develop drug malaria profit cholesterollow drug market year earlier thi prioriti review worth hundr dollar bill gate econom forum davo latest news reaction concern prioriti review voucher access follow link http newsgooglecomnew hlen nedu btngsearchnew limit voucher prize small diseas incred burden merit resourc advanc market commit propos michael kremer colleagu call creat billion market neglect diseas high burden malaria tuberculosi hivaid second voucher prize larg reward low valu aidan holli univers calgari note firm develop veri profit product will reward treatment neglect diseas lucr thi gener rule whi diseas neglect third voucher prize encourag innov doe pay access exist therapi fund govern foundat purchas treatment poor peopl aidan holli univers calgari ha comment propos doe address access problem help increas incent creat distort market develop countri fourth voucher prize tie fda resourc fortun howev law includ extra fee paid manufactur fda requir voucher bearer provid fda year notic befor voucher refer develop drug develop countri ridley al health affair http wwwbvghorgdocumentsbrownbackbrownanalysisfinalpdf hr bill gate bill melinda gate foundat sourc market incent encourag innov global health bio ventur global health http wwwbvghorgdocumentsbrownbackbrownanalysisfinalpdf extern link paper coauthor david ridley talk prioriti review voucher nation press club video http wwwkaisernetworkorghealth_casthcast_indexcfm createhigh_window displaydetail financi time coverag prioriti review voucher professor aidan holli critiqu prioriti reviewvouch